Works cited by this work

164 works

Work: Invisible influencers: the tumor microbiome’s impact on immunotherapy in colorectal cancer (CRC)

1. Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

   Vancheswaran Gopalakrishnan, C. N. Spencer, Luigi Nezi +67

   Article20176 citations

   ABIABI:AkademIndex/openalex/2026.other.339918

2. Regulatory mechanisms of PD-1/PD-L1 in cancers

   Xin Lin, Kuan Kang, Pan Chen +5

   Article20245 citations

   ABIABI:AkademIndex/openalex/2026.other.102973

3. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

   Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

   Article20175 citations

   ABIABI:AkademIndex/openalex/2026.other.339917

4. Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4

   Madhukumar Venkatesh, Subhajit Mukherjee, Hongwei Wang +16

   Article20143 citations

   ABIABI:AkademIndex/openalex/2026.other.014288

5. Innate and adaptive immune cells in the tumor microenvironment

   Thomas F. Gajewski, Hans Schreiber, Yang‐Xin Fu

   Review article20133 citations

   ABIABI:AkademIndex/openalex/2026.other.091362

6. A human gut microbial gene catalogue established by metagenomic sequencing

   Junjie Qin, Ruiqiang Li, Jeroen Raes +50

   Article20103 citations

   ABIABI:AkademIndex/openalex/2026.other.339877

7. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

   Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35

   Article20153 citations

   ABIABI:AkademIndex/openalex/2026.other.339891

8. The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

   Vyara Matson, Jessica Fessler, Riyue Bao +5

   Article20183 citations

   ABIABI:AkademIndex/openalex/2026.other.468889

9. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

   Erez N. Baruch, Ilan Youngster, Guy Ben‐Betzalel +29

   Article20203 citations

   ABIABI:AkademIndex/openalex/2026.other.468906

10. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients

    Diwakar Davar, Amiran Dzutsev, John A. McCulloch +29

    Article20213 citations

    ABIABI:AkademIndex/openalex/2026.other.468908

11. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

    Takeshi Tanoue, Satoru Morita, Damian R. Plichta +25

    Article20192 citations

    ABIABI:AkademIndex/openalex/2026.other.014327

12. Drug-Resistant <i>E. coli</i> Bacteremia Transmitted by Fecal Microbiota Transplant

    Zachariah DeFilipp, Patricia P. Bloom, Mariam Torres Soto +7

    Article20192 citations

    ABIABI:AkademIndex/openalex/2026.other.014333

13. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?

    S Deleu, Kathleen Machiels, Jeroen Raes +2

    Review article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.042810

14. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

    Ara Koh, Filipe De Vadder, Petia Kovatcheva‐Datchary +1

    Review article20162 citations

    ABIABI:AkademIndex/openalex/2026.other.220012

15. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma

    Melissa Borgia, Michele Dal Bo, Giuseppe Toffoli

    Review article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.289803

16. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

    William R. Wikoff, Andrew Anfora, Jun Liu +4

    Article20092 citations

    ABIABI:AkademIndex/openalex/2026.other.320183

17. Microbiota: a key orchestrator of cancer therapy

    Soumen Roy, Giorgio Trinchieri

    Review article20172 citations

    ABIABI:AkademIndex/openalex/2026.other.339910

18. Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer

    Susan Bullman, Chandra Sekhar Pedamallu, Ewa Sicińska +26

    Article20172 citations

    ABIABI:AkademIndex/openalex/2026.other.339919

19. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment

    Mackenzie Bender, Alex McPherson, Catherine M. Phelps +22

    Article20232 citations

    ABIABI:AkademIndex/openalex/2026.other.339999

20. <i>Roseburia intestinalis</i> generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8 ⁺ T cells

    Xing Kang, Changan Liu, Yanqiang Ding +7

    Article20232 citations

    ABIABI:AkademIndex/openalex/2026.other.340005

21. Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer

    Pasquale Marino, Mariangela Mininni, Giovanni Deiana +7

    Article20242 citations

    ABIABI:AkademIndex/openalex/2026.other.340013

22. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment

    Jiachun Lian, Yanfang Liang, Hailiang Zhang +5

    Review article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.340581

23. Nanoparticle biointerfacing by platelet membrane cloaking

    Che‐Ming Jack Hu, Ronnie H. Fang, Kuei-Chun Wang +19

    Article20152 citations

    ABIABI:AkademIndex/openalex/2026.other.468882

24. Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation

    Marta Wlodarska, Chengwei Luo, Raivo Kolde +19

    Article20172 citations

    ABIABI:AkademIndex/openalex/2026.other.468887

25. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota

    Danfeng Chen, Duochen Jin, Shumin Huang +12

    Article20192 citations

    ABIABI:AkademIndex/openalex/2026.other.468898